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Abstract 
Background. Preterm birth (PTB) is the leading cause of neonatal mortality and 
morbidity. PTB is often classified according to clinical presentation: Idiopathic (PTB-I), 
preterm premature rupture of membranes (PTB-PPROM), and medically induced (PTB-
M). The aim of this study was to evaluate the associations between specific candidate 
genes and clinical subtypes of PTB. 
Methods. 24 SNPs were genotyped in 18 candidate genes in 709 infant triads. Of 
them, 243 were PTB-I, 256 PTB-PPROM, and 210 PTB-M. These data were analyzed 
with a Family-Based Association. 
Results. PTB was nominally associated with rs2272365 in PON1, rs883319 in 
KCNN3, rs4458044 in CRHR1, and rs610277 in F3. Regarding clinical subtypes 
analysis, 3 SNPs were associated with PTB-I (rs2272365 in PON1, rs10178458 in 
COL4A3, and rs4458044 in CRHR1), rs610277 in F3 was associated with PTB-
PPROM, and rs883319 in KCNN3 and rs610277 in F3 were associated with PTB-M. 
Conclusions. Our study identified polymorphisms potentially associated with 
specific clinical subtypes of PTB in this Latin American population. These results could 
suggest a specific role of such genes in the mechanisms involved in each clinical 
subtype. Further studies are required to confirm our results and to determine the role of 
these genes in the pathophysiology of clinical subtypes. 
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Introduction 
Preterm birth (PTB), defined as gestational age (GA) less than 37 weeks, is the 
leading cause of neonatal mortality and morbidity, with an estimated incidence of 5-
12% depending on the geographic region(1-2). The rate of PTB in Argentina in 2014 
was estimated to be 8% (http://deis.msal.gov.ar). PTB is considered a complex and 
abnormal pregnancy outcome resulting from the interplay of several genetic and 
environmental factors(3), and a history of a preterm delivery is the single greatest 
predictor of a future preterm delivery(4). The role of other proposed predictors, such as 
maternal factors (e.g., short inter-pregnancy interval, multiple gestations), genetic 
mechanisms due high recurrence with previous PTB (e.g., familial aggregation), 
environment (e.g., low socio-economic status), or an interaction between these, remains 
largely unknown(5). 
Preterm birth is often categorized into sub-groups of varying severity. Sub-
groups are typically determined based on GA (Gestational Age) (i.e., GA<32 weeks, 
GA= 32-36 weeks) or clinical presentation (idiopathic (PTB-I), preterm premature 
rupture of membranes (PTB-PPROM), or medical inducement (PTB-M)(6). The clinical 
subtypes PTB-I and PTB-PPROM are together designated as spontaneous preterm birth 
(PTB-S). Given the heterogeneity observed in PTB, it is helpful to examine these 
categories separately with regard to etiology, prevention, and intervention(7). However, 
differences among these preterm birth subtypes have not been fully explored in Latin 
American populations, and few epidemiological and genetic association studies of 
clinical subtypes in any population have been completed(8-10). 
In the current study, we attempted to replicate previous candidate gene 
associations that predispose individuals to specific clinical subtypes of PTB in a Latin 
American population(10-12). Candidate gene associations in complex diseases, such as 
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PTB, are frequently difficult to replicate, largely because of heterogeneity between 
populations and the unique characteristics of different study populations(13). 
Specifically, the associated causative alleles often have different frequencies across 
diverse populations. Moreover, the contribution of genetic admixtures to PTB is not 
known, although significant racial differences exist in PTB(6, 10). Genetic admixture 
studies with Latin American populations have demonstrated large geographic variability 
in the Amerindian and European contributions to Latin American ancestry. For 
example, an Argentine population was found to have extensive paternal directional 
mating between historic populations of European fathers and Amerindian mothers, 
resulting in a unique genetic admixture(14-15). The aim of this genetic association 
study was to identify single nucleotide polymorphism (SNPs) associated with specific 
clinical subtypes of PTB in a Latin American population. Eighteen candidate genes 
were chosen for this work based on biological plausibility and previous associations 
with preterm birth(11, 16). The current study was conducted at a single site in Argentina 
and included 709 preterm trios (neonate and parents). 
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Methods 
The study procedures were approved by the Centro de Educación Médica e 
Investigaciones Clínicas (CEMIC) Ethics Committee (IRB 00001745 – IORG 0001315) 
and the University of Iowa Institutional Review Board (IRB 200411759). Individuals 
were recruited from Nuestra Señora de la Merced Maternity Hospital in Tucumán-
Argentina. Parents were recruited to the study and provided consent for themselves and 
the neonate. Neonatal samples were taken from placental cord blood, and parents 
provided a peripheral blood or saliva sample. Extraction of DNA from biological 
samples was completed at either CEMIC in Buenos Aires or the University of Iowa. 
The current study included families of neonates born between July 2005 and 
December 2010. Inclusion criteria for the study were singleton neonates delivered at 
less than 37 weeks of gestational age. Neonates were excluded for the following 
reasons: congenital anomalies, multiple gestation, or maternal age less than 14 years. 
Cases were identified using the daily delivery room records (births were registered 
within 24 hours or in the immediate postpartum period). 
Clinical subtypes. Three clinical subtypes were identified in accordance with 
recently developed research guidelines for conducting epidemiological genetic studies 
of PTB(1, 6). The data on the onset of labor were regularly registered in the clinical 
perinatal record by the obstetrician. Based on this categorization, preterm deliveries at 
the hospital were classified by researchers as follows: 
1. PTB-I: preterm labor leading to PTB (idiopathic), diagnosed as cervical change 
(dilation and effacement) due to regular uterine activity. A rupture of 
membranes was only included in this category when the rupture occurred during 
active labor. 
©    2017 Macmillan Publishers Limited. All rights reserved.
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2. PTB-PPROM: preterm premature rupture of the membranes diagnosed by pelvic 
examination or obvious leakage of fluid from the cervix into the posterior fornix. 
If it was unclear whether PPROM had occurred, an ultrasound was performed to 
identify oligohydramnios. Membrane rupture had to occur before the onset of 
labor regardless of the means of delivery.  
3. PTB-M: a medical condition existed that required delivery before 37 weeks 
gestation (i.e., preeclampsia). 
 The subtypes PTB-I and PTB-PPROM are together designated spontaneous 
preterm birth (PTB-S). The preterm births were classified into subtypes by two 
independent researchers. Cases were reviewed by the principal investigator if the 
independent researchers disagreed on the classification. 
 Sample genotyping. Twenty-four SNPs in 18 candidate genes (F3, IL6R, 
KCNN3, CR1, FSHR, IL1B, FN1, COL4A3, PON1, TRAF2, F2, SERPINH1, PGR, 
IGF1, INF2, IGFIR, CRHR1, TIMP2) were genotyped in the current cohort. Candidate 
genes were selected based on previous significant associations with PTB(10-12, 16-17). 
Genotyping of SNP markers was performed using Taqman probes (Applied Biosystems, 
Foster City, California) and the Fluidigm SNP Genotyping platform (192.24 Dynamic 
Array) as previously described(18). 
All SNP genotyping assays were available and ordered using the Assay-on-
Demand service from Applied Biosystems. These genotyping assays included primers 
to amplify the region containing the SNP of interest and two TaqMan Minor Groove 
Binder probes specific to the polymorphic variant alleles at the site labeled with 
different fluorescent reporter dyes, FAM and VIC. All reactions were performed using 
standard conditions supplied by Fluidigm. Following thermocycling, fluorescence levels 
©    2017 Macmillan Publishers Limited. All rights reserved.
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of the FAM and VIC dyes were measured using the EP1 Reader and genotypes were 
scored using the Fluidigm Genotyping Analysis software. 
Genotyping was completed on 709 preterm triads (mother-father-child). 
Genotypes were entered into a laboratory database (Progeny, South Bend, IN) to 
generate datasets for analysis.  
 Data Analysis. Genotyping quality controls were performed before completing 
the analysis (e.g., missing genotype rate by individual and by SNP, minor allele 
frequency (<0.05), Hardy-Weinberg equilibrium failures for each SNP, and Mendelian 
Error rate) using PLINK software(19). Alleles at each marker were tested for an 
association using Family Based Association (Transmission Disequilibrium Test (TDT)) 
to look for nonrandom allele transmission from parents to offspring(20). The units of 
analysis were analyzed using PLINK software to investigate differences in transmission. 
The P values obtained in this study were corrected for multiple testing (Bonferroni 
correction P value <0.00208 using an α of 0.05). However, given the exploratory nature 
of this initial study, less stringent values were also of interest. With 700 triads (mother-
father-child), we reached a statistical power of 80% to identify a recessive allele that 
acts additively and increases the risk at least two-fold compared to a reference allele 
with a frequency of 10% in the population. 
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Results 
We studied a total of 709 infant triads, of which 499 were classified as 
“spontaneous” (PTB-I+PTB-PPROM) and 210 as PTB-M. From PTB-S, 243 were 
classified as PTB-I, and 256 were classified as PTB-PPROM (Table 1). A complete list 
of the 24 SNPs and 18 candidate genes that were genotyped is shown in Table 2. 
Using a TDT (Transmission Disequilibrium Test), we identified four SNPs 
associated with PTB that were nominally significant (p<0.05) (Table 3). These SNPs 
were rs2272365 in PON1 (p=0.002, OR=1.48, CI=1.15-1.90), rs610277 in F3 (p=0.002, 
OR=1.96, CI=1.26-3.05), rs883319 in KCNN3 (p=0.008, OR=1.32, CI=1.07-1.63), and 
rs4458044 in CRHR1 (p=0.020, OR=1.21, CI=1.02-1.42). The association rs2272365 in 
PON1 was the only one that remained significant after a Bonferroni correction. The 
marker rs610277 in F3 showed borderline significance after correction. 
Three SNPs were associated with PTB-I (rs2272365 in PON1 (p=0.005, 
OR=1.87, CI=1.20-2.91), rs10178458 in COL4A3 (p=0.015, OR=1.78, CI=1.11-2.85), 
and rs4458044 in CRHR1 (p=0.041, OR=1.32, CI=1.01-1.73)), one SNP was associated 
with PTB-PPROM (rs610277 in F3 (p=0.023, OR=2.30, CI=1.09-4.83)), and two SNPs 
were associated with PTB-M (rs883319 in KCNN3 (p=0.006, OR=1.74, CI=1.17-2.59) 
and rs610277 in F3 (p=0.015, OR=2.62, CI=1.16-5.93)) (Table 3). No associations 
remained significant after Bonferroni correction. 
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Discussion 
Using a family-based approach, we found that three markers were nominally 
associated with PTB-I (PON1, COL4A3, and CRHR1), one marker (F3) was associated 
with PTB-PPROM, and two markers were associated with PTB-M (F3 and KCNN3). 
These findings are consistent with previous literature, in that the SNPs associated with 
the clinical subtypes of PTB in this study are involved in at least one of the four main 
biological mechanisms that could lead to PTB: (i) activation of the maternal or fetal 
hypothalamic pituitary-adrenal axis, (ii) inflammation and infection, (iii) decidual 
hemorrhage, and (iv) uterine distention(21). 
A recent meta-analysis by Capece et al. (2014) used approximately 3600 cases 
and controls and analyzed 2175 SNPs in 274 genes for association with the PTB-
Idiopathic and PTB-PPROM subtypes. Significant associations of PTB-I and PTB-
PPROM were found for 248 SNPs in 102 genes and 39 SNPs in 32 genes, respectively 
(2). The authors propose an autoimmune/hormonal process for PTB-I and a 
hematologic/coagulation function disorder, collagen metabolism, matrix degradation 
and local inflammation for PTB-PPROM. Our study replicated the significant findings 
found for three of the markers associated with PTB-I (PON1, COL4A3, and CRHR1) 
and one of the markers associated with PTB-PPROM (F3). 
PON1 is involved in the decidual hemorrhage pathway and is thought to 
potentially activate biochemical mediators, such as matrix metalloproteinases (MMPs), 
which can in turn cause extracellular matrix (ECM) degradation and may lead to 
preterm birth via the initiation of early contractions, cervical ripening, and rupture of the 
PTB membranes(16). Specifically, previous studies have hypothesized that mutations in 
PON1 may indirectly activate thrombin and plasminogen cascades, which can result in 
ECM degradation, changes in the cervix, and rupture of the membrane(22-23). 
©    2017 Macmillan Publishers Limited. All rights reserved.
11 
 
Additionally, in vitro studies have shown that mutations in PON1 are associated with 
changes in lipid profiles (HDL and LDL)(24-25), and the incubation of endothelial cells 
with HDL increases the production of prostaglandin E2, leading to premature uterine 
contractions(26). Thus, the findings of the current study support previous research 
indicating that genetic variation in PON1 may lead to PTB-I. 
The COL4A3 gene encodes a structural protein that is a constitutive element of 
the extracellular matrix and is the main component responsible for maintaining the 
structure of the basement membrane of the amnion, chorion, and uterine cervix(27). 
Previous work by Romero et al. (2010) used a haplotype analysis of genes (COL4A3, 
IL6R, LTF and FGF1) associated with PTB-I in a Hispanic population in Chile, and 
COL4A3 emerged as the marker with the highest significance(11). Therefore, previous 
and current work supports that variants in genes involved in extracellular matrix 
metabolism, such as collagen type IV alpha-3 chain (COL4A3) and degradation 
regulators of this structure (e.g., tissue inhibitor of metalloproteinase 2 (MMP-2)), could 
increase the risk of preterm labor. 
CRHR1, which is involved in the receptor activity of the corticotropin releasing 
factor, was previously linked to preterm birth in a study by Bream et al. (2013)(17). 
Importantly, plasma CRH levels increase exponentially during pregnancy, with a peak 
during childbirth, and women who deliver preterm have a more rapid increase in CRH 
levels in early pregnancy(28) and in the last trimester of pregnancy. This suggests that 
the length of the gestational period may be predetermined and activated when CRH 
reaches its maximum expression and provides a plausible biological mechanism for the 
involvement of CRHR1in the etiology of preterm birth. 
The PTB-PPROM subtype was associated with a marker in F3. F3 or 
coagulation factor III is a membrane glycoprotein present in the fibroblasts of the wall 
©    2017 Macmillan Publishers Limited. All rights reserved.
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of blood vessels and other cells. The placental decidua is rich in the tissue factor 
encoded by F3, which acts as the primary initiator of hemostasis(29). Placental 
abruption (hemorrhage into the uterine decidua) is evident in the histological 
examination of over 60% of preterm births. After hemorrhage, the tissue factor binds to 
the membrane of the decidual cells and forms a complex with the activated factor VII, 
which in turn activates thrombin generated factor X. The binding of thrombin to its 
receptors enhances the production of enzymes that degrade the decidual and fetal 
membranes(30). Additionally, thrombin binds to myo-metrial receptors, resulting in 
early uterine contractions. In sum, the tissue factor encoded by F3 has been implicated 
in the degradation of placental membranes and the initiation of uterine contractions in 
PTB.  
The etiology of PTB-M is difficult to establish because the determinants of this 
condition are very heterogeneous and include preeclampsia, fetal distress, small-for-
gestational (SGA), and placental abruption(8). Despite the limitations of this clinical 
subtype, the current study identified that a marker in KCNN3 was associated with PTB-
M. KCNN3 is expressed in tissues responsible for maintaining gestation and inducing 
parturition(31) and is subject to regulation by estrogen(32), providing a feasible 
biological mechanism for KCNN3 in the etiology of preterm labor(33-34). Day and 
colleagues (2011) previously identified a significant association between markers in 
KCNN3 and preterm birth(35), and an associated study of Argentine women who 
delivered preterm identified the same marker as the current study(10). Moreover, a 
study by Rada et al. (2012) utilized a mouse model and found that alterations in SK3 
channel expression or function may incur a risk of cardiovascular-related disorders 
during pregnancy(36). The KCNN3 channel is a key regulator of an angiogenic 
endothelium-mediated feedback pathway that must be properly regulated to maintain a 
©    2017 Macmillan Publishers Limited. All rights reserved.
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successful pregnancy(37). Disruption of this pathway can result in deleterious effects 
due to improper placental vascularization and thus may play a role in pregnancy 
disorders that increase the risk of preeclampsia and PTB. 
The current study has several limitations that should be considered when 
interpreting the findings. First, the individuals were recruited from a single maternity 
hospital, as it was not possible to include different regions of the world for comparison, 
limiting the generalizability of the current findings. Second, only one marker 
maintained statistical significance after correction for multiple comparisons. However, 
it is known that associated studies of candidate genes in complex diseases such as PTB 
are frequently difficult to replicate, and this may be due to the genetic heterogeneity 
across populations. 
 A typical problem of genetic association studies with a case-control design is the 
identification of spurious associations due to bias from population stratification. 
Therefore, a family-based association study with more than 700 triads (mother-father-
child) was used in this study to avoid this potential bias. The current study is one of the 
larger family-based studies of genetic associations with clinical subtypes of PTB in a 
Latin American population. 
 
 
 
 
 
 
 
 
©    2017 Macmillan Publishers Limited. All rights reserved.
14 
 
Conclusions 
The current study suggests that different genetic influences are associated with 
the different clinical subtypes of preterm birth (PTB) in a Latin American population. 
The current approach allowed for the identification of SNPs specific to the different 
subtypes of PTB as well as SNPs shared by all subtypes of PTB. The SNPs in PON1, 
COL4A3 and CRHR1 were associated with the PTB-I subtype, an SNP in F3 was 
associated with the PTB-PPROM subtype, and SNPs in KCNN3 and F3 were associated 
with the PTB-M subtype. These findings may lead to a better understanding of the 
pathophysiology of clinical subtypes of PTB and therefore better prevention of PTB. 
However, adding additional cohorts from different regions of Latin America is 
important to expand these findings to other populations and thus contribute more 
knowledge to the etiology of specific clinical subtypes of PTB. 
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Table 1. Demographic characteristics of the study population by clinical subtypes. 
 PTB-I PTB-PPROM PTB-M P value 
N 
(individuals/triads) 
729/243 768/256 630/210 - 
Maternal age  
(years)  
22.8 (+/- 5.6) 24.8 (+/- 6.2) 27.0 (+/- 6.4) <0.001 
Gestational age at 
delivery (weeks) 
32.7 (+/- 3.2) 32.6 (+/- 2.9) 33.1 (+/- 2.7) 0.283 
Birth weight 
(grams)  
1871(+/- 566) 1811 (+/- 557) 1762 (+/- 579) 0.122 
Gestational age<32 
weeks N (%) 
71 (29.1) 79 (30.9) 51 (24.3) 0.267 
Infant gender N (% 
male) 
131 (53.7) 136 (53.3) 103 (49.0) 0.553 
Note. PTB-I is PTB-Idiopathic; PTB-PPROM is PTB-Preterm Premature Rupture 
of Membranes; and PTB-M is PTB-Medically Indicated. ANOVA was used for 
continuous variables (maternal age, gestational age, and birth weight) and Pearson 
chi-square was used for dichotomized variables (gestational age <32  and gender). 
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Table 2. SNPs genotyped in the current study 
Gene name Gene 
symbol 
Chr SNPs MAF Functional 
consequence 
Encoded (Protein coding) 
Coagulation factor III 
precursor 
F3 1 rs610277 0.040 Intron variant Surface glycoprotein 
Interleukin 6 receptor isoform 
1 
Il6R 1 rs8192282 0.059 Synonymous codon Interleukin 6 (IL6) receptor 
complex 
Potassium channel, calcium-
activated, intermediate/small 
conductance, subfamily N 
alpha, Member 3 
KCNN3 1 rs883319 0.193 Intron variant Small conductance calcium-
activated potassium channel 3 
(integral membrane protein) 
Complement component 
receptor 1 
CR1 1 rs6691117 0.336 Missense Monomeric single-pass type I 
membrane glycoprotein 
Follicle-stimulating hormone 
receptor 
FSHR 2 rs11686474 0.438 Intron variant Transmembrane receptor 
Interleukin 1, beta proprotein IL1B 2 rs1143643 0.262 Intron variant Cytokineprotein Interleukin 1 
Fibronectin 1 isoform 3 
preproprotein 
FN1 2 rs2304573 0.428 Intron variant Glycoprotein fibronectin 
Alpha 3 type IV collagen 
isoform 1 
COL4A3 2 rs1882435; 
rs10178458 
0.286; 
0.105 
Intron variant, Missense Type IV collagen, (multimeric 
protein composed of 3 alpha 
subunits) 
Paraoxonase 1 PON1 7 rs854552;  
rs2272365 
0.35; 
0.126 
UTR variant 3 prime, 
Intron variant 
Enzyme paroxon 
(organophosphate) 
TNF receptor-associated 
factor 2 
TRAF2 9 rs3750512; 
rs4880166 
0.490; 
0.392 
Downstream variant 
500B,utr variant 3 prime 
TNF receptor associated 
factor 2 
Coagulation factor II, 
thrombin 
F2 11 rs1799963 0.003 Downstream variant 
500B,utr variant 3 prime 
Coagulation factor II 
Serpin peptidase inhibitor, 
clade h, member 1 
SERPINH
1 
11 rs667531 0.306 Upstream variant 2KB Glycoproteins that bind 
specifically to collagen type I 
Progesterone receptor PGR 11 rs1942836 0.363 Possible regulatory 
regions 
Progesterone receptor, a member 
of the steroid receptor superfamily 
Insulin-like growth factor 1 
(somatomedin C) 
IGF1 12 rs5742612 0.139 Intron variant,upstream 
variant 2KB 
Hormone IGF1 
Inverted formin 2 INF2 14 rs7153053 0.343 - Protein family called the formins 
Insulin-like growth factor 1 IGFIR 15 rs7165181; 0.402; Intron variant Insulin-like growth factor I 
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receptor rs4966038 0.433 receptor (transmembrane receptor) 
Corticotropin-releasing 
hormone receptor 1 
CRHR1 17 rs7225082; 
rs4458044; 
rs173365 
0.317; 
0.374; 
0.304 
Intron variant 
 
Corticotropin-releasing hormone 
receptor 
Tissue inhibitor of 
metalloproteinase 2 
TIMP2 17 rs2277698 0.113 Synonymous codon Proteins inhibitors of the matrix 
metalloproteinases 
Note. MAF: Minor Allele Frequency estimated from the sample studied. Chr is the chromosome number.  
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Table 3.  Candidate gene associations for PTB and clinical subtypes.  
 
 Informative N Gene SNP rs A1 A2 Ratio T/UTa ORb CIc P value 
All PTB (N=709) 
89 F3 rs610277 G A 59/30 1.96 1.26, 3.05 0.002 
253 PON1 rs2272365 G T 151/102 1.48 1.15, 1.90 0.00206* 
358 KCNN3 rs883319 T C 204/154 1.32 1.07, 1.63 0.008 
584 CRHR1 rs4458044 C G 320/264 1.21 1.02, 1.42 0.020 
PTB-I (N=243) 
86 PON1 rs2272365 G T 56/30 1.87 1.20, 2.91 0.005 
75 COL4A3 rs10178458 T C 48/27 1.78 1.11, 2.85 0.015 
216 CRHR1 rs4458044 C G 123/93 1.32 1.01, 1.73 0.041 
PTB-PPROM (N=256) 33 F3 rs610277 G A 23/10 2.30 1.09, 4.83 0.023 
PTB-M (N=210) 104 KCNN3 rs883319 T C 66/38 1.74 1.17, 2.59 0.006 29 F3 rs610277 G A 21/8 2.62 1.16, 5.93 0.015 
Note. All N are numbers of triads; PTB-S is PTB-Spontaneous (PTB-I+PTB-PPROM); PTB-I is PTB-Idiopathic; PTB-PPROM is 
PTB-Preterm Premature Rupture of Membranes; PTB-M is PTB-Medically Indicated; a Ratio transmitted and un-transmitted 
alleles; b Odds ratio (risk of allele 2 (A2) in reference to Allele 1 (A1)); c Confidence interval. *remained significant after 
correction for Bonferroni correction (p value <0.00208) 
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